themis Antibody

What is THEMIS and why is it significant in T-cell research?

THEMIS is a 72 kDa cytosolic phosphoprotein (641 amino acids) predominantly expressed in late double-negative and double-positive thymocytes. It plays a crucial role in T-cell development by regulating both positive and negative T-cell selection. THEMIS functions as an analog-to-digital converter that translates graded T-cell receptor (TCR) affinity into clear selection outcomes by specifically attenuating TCR signal strength in response to low but not high-affinity TCR engagement . This regulation is essential for proper lineage commitment and maturation of T-cells, making THEMIS a critical protein in the study of adaptive immunity and T-cell development .

How does THEMIS regulate T-cell receptor signaling?

THEMIS regulates TCR signaling through several mechanisms. It primarily acts by controlling SHP1 (Src-homology domain containing phosphatase-1) recruitment and activation. THEMIS positively regulates SHP1 phosphatase activity in thymocytes, and this activity is reduced in the absence of THEMIS . By moderating signal strength and kinetics of responses to relatively low-affinity ligands, THEMIS establishes a threshold that distinguishes between positive and negative selection stimuli . Additionally, THEMIS regulates calcium influx and phosphorylation of ERK (extracellular signal-regulated kinase) in response to TCR stimulation, further contributing to its role in signal modulation .

What are the main applications of THEMIS antibodies in immunological research?

THEMIS antibodies are valuable tools in several experimental applications:

• Western blotting: For detecting and quantifying THEMIS protein expression in cell lysates

• Immunoprecipitation: For isolating THEMIS and studying its interacting partners

• Flow cytometry: For analyzing THEMIS expression in different T-cell populations

• Immunofluorescence: For visualizing cellular localization of THEMIS

• ELISA: For quantitative measurement of THEMIS in samples

These applications enable researchers to investigate THEMIS expression patterns, protein interactions, and functional roles in various experimental contexts .

What factors should be considered when selecting a THEMIS antibody for specific applications?

When selecting a THEMIS antibody, researchers should consider several critical factors:

• Validated applications: Ensure the antibody has been validated for your intended application (WB, IP, FC, etc.)

• Species reactivity: Verify the antibody recognizes THEMIS in your species of interest (human, mouse, rat)

• Clonality: Monoclonal antibodies offer high specificity for a single epitope, while polyclonal antibodies recognize multiple epitopes

• Immunogen: Check which region of THEMIS the antibody was raised against, as this affects epitope accessibility

• Host species: Consider compatibility with other antibodies in multi-labeling experiments

• Validation data: Review available validation data showing specificity and performance

For example, R&D Systems Human Themis Antibody (MAB6929) has been validated for flow cytometry in human blood lymphocytes, while other antibodies like those from Abcam (ab241476) have been validated for Western blot and immunoprecipitation applications .

What are the optimal protocols for THEMIS detection in Western blot applications?

For optimal THEMIS detection in Western blot applications:

Sample preparation:

• Prepare cell lysates using appropriate lysis buffer (NETN lysis buffer works well)

• Include protease and phosphatase inhibitors to prevent degradation

• Use 30-50 μg of total protein per lane

Gel electrophoresis and transfer:

• Separate proteins on 8-10% SDS-PAGE (THEMIS is ~72 kDa)

• Transfer to PVDF or nitrocellulose membrane

Antibody incubation:

• Block membrane with 5% non-fat milk or BSA in TBST

• Incubate with primary anti-THEMIS antibody at manufacturer's recommended dilution (e.g., Abcam ab241476 at 0.1 μg/mL)

• Incubate overnight at 4°C

• Wash thoroughly with TBST

• Incubate with appropriate HRP-conjugated secondary antibody

• Develop using ECL substrate

Controls:

• Include positive control (thymocyte lysate)

• Include negative control (non-T cell lysate or THEMIS knockout sample)

• Use housekeeping protein (β-actin, GAPDH) as loading control

How can flow cytometry be optimized for THEMIS detection in T-cell populations?

For optimal THEMIS detection by flow cytometry:

Sample preparation:

• Prepare single-cell suspensions from thymus or peripheral blood

• For co-staining, include surface markers like CD3, CD4, CD8 before fixation

• Fix cells with 2-4% paraformaldehyde

• Permeabilize with 0.1% saponin or commercial permeabilization reagents

Staining protocol:

• Block Fc receptors with anti-CD16/CD32 antibodies to reduce non-specific binding

• Stain with anti-THEMIS antibody at optimized concentration

• For indirect detection, use appropriate fluorochrome-conjugated secondary antibody

• Include lineage markers to identify relevant T-cell populations

Controls:

• Unstained control for autofluorescence

• Isotype control at same concentration as THEMIS antibody

• FMO (fluorescence minus one) controls for proper gating

• Biological controls (THEMIS-negative and positive populations)

As demonstrated in R&D Systems' protocol, human peripheral blood lymphocytes can be successfully stained with Mouse Anti-Human THEMIS Monoclonal Antibody followed by PE-conjugated Anti-Mouse IgG Secondary Antibody along with CD3e APC-conjugated antibody for T-cell identification .

What are common challenges in THEMIS detection and how can they be addressed?

Common challenges in THEMIS detection include:

Western blot challenges:

• Weak or absent signal: Increase protein loading (50-100 μg), optimize antibody concentration, extend incubation time, use more sensitive detection reagents

• High background: Increase blocking time, use fresh blocking reagent, optimize antibody dilution, increase washing stringency

• Multiple bands: Verify antibody specificity, check for degradation by adding fresh protease inhibitors, consider post-translational modifications

Flow cytometry challenges:

• Low signal: Optimize fixation/permeabilization, increase antibody concentration, extend incubation time

• High background: Use Fc receptor blocking, optimize antibody dilution, include proper controls

• Poor discrimination: Adjust instrument settings, use brighter fluorochromes, ensure proper compensation

When troubleshooting, systematically test each variable while keeping others constant to identify the source of the problem. Including positive controls (thymocytes expressing high THEMIS levels) and negative controls (non-T cells or THEMIS-knockout samples) is essential for validating results .

How should THEMIS expression be interpreted in different T-cell developmental stages?

THEMIS expression follows a distinctive pattern across T-cell development:

• Thymocyte stages: Highest expression in late double-negative (DN) and double-positive (DP) thymocytes undergoing selection; more moderate in single-positive (SP) thymocytes

• Peripheral T-cells: Maintained in naïve T-cells but expression patterns may change upon activation

• Helper T-cell subsets: Selectively increased in TH1 cells compared to other T-helper subsets

When interpreting THEMIS expression data:

• Normalize to appropriate controls for quantitative comparisons

• Consider developmental context—high expression correlates with stages where TCR signal modulation is critical

• Note that THEMIS has different functions in thymic versus peripheral T-cells

• Be aware that THEMIS may have opposing effects in naïve versus effector T-cells

The functional significance of varying THEMIS expression includes its role in setting TCR signaling thresholds during selection and its promotion of TH1 cell responses through T-BET expression and IFN-γ production .

How can contradictory results in THEMIS research be reconciled?

Contradictory findings in THEMIS research often reflect its context-dependent functions. To reconcile such discrepancies:

• Evaluate experimental context differences:

  • Cell types and activation states: THEMIS has opposing effects in naïve versus effector T-cells

  • TCR signal strength: THEMIS attenuates signaling in response to low but not high-affinity TCR engagement

  • In vitro versus in vivo settings: THEMIS shows inhibitory effects on naïve CD4+ T-cells in vitro but stimulatory effects in vivo

• Compare experimental timelines:

  • Acute versus chronic effects may differ

  • Developmental timing matters (thymic selection versus peripheral activation)

• Analyze genetic backgrounds:

  • Different mouse strains may show varying phenotypes

  • Consider compensatory mechanisms in complete versus conditional knockouts

For example, initial studies suggested THEMIS attenuates TCR signaling , while later research revealed it enhances TH1 cell responses . This apparent contradiction was resolved by recognizing that THEMIS has TCR-dependent inhibitory functions in developing thymocytes but TCR-independent stimulatory effects in effector T-cells .

How can THEMIS antibodies be used to investigate THEMIS-SHP1 interactions?

THEMIS antibodies are valuable tools for investigating the critical THEMIS-SHP1 interaction:

Co-immunoprecipitation approaches:

• Immunoprecipitate THEMIS using specific antibodies and probe for SHP1 in the precipitate

• Use gentler lysis buffers (1% digitonin or CHAPS) to preserve protein interactions

• Include phosphatase inhibitors to maintain phosphorylation-dependent interactions

• Compare resting versus stimulated conditions to detect dynamic interactions

Phosphatase activity assays:

• Immunoprecipitate THEMIS-SHP1 complexes using THEMIS antibodies

• Measure phosphatase activity in the precipitate using sensitive phosphatase activity assays

• Research has shown that THEMIS positively regulates SHP1 phosphatase activity in thymocytes

Proximity-based detection:

• Use proximity ligation assays with antibodies against both THEMIS and SHP1

• This technique generates fluorescent signals only when proteins are in close proximity

• Allows visualization of interactions in intact cells

These approaches have revealed that THEMIS interacts with SHP1 and controls the threshold between positive and negative selection of thymocytes through regulation of SHP1 activity .

What approaches can be used to study THEMIS in T-cell signaling complexes?

Advanced approaches for studying THEMIS within signaling complexes include:

Biochemical approaches:

• Sequential immunoprecipitation to isolate specific complexes

• Blue native PAGE to preserve protein complexes for analysis

• Crosslinking prior to immunoprecipitation to capture transient interactions

Imaging techniques:

• Confocal microscopy with co-localization analysis

• FRET/FLIM to detect molecular proximity in live cells

• Super-resolution microscopy for nanoscale localization

• Using antigen-presenting lipid bilayers for imaging THEMIS during immunological synapse formation

Functional signaling studies:

• Calcium flux assays in THEMIS-sufficient versus deficient cells

• Phospho-flow cytometry to analyze multiple signaling events simultaneously

• Analysis of downstream transcriptional responses

When studying TCR-stimulated signaling, researchers can stimulate cells with tetramers, antibodies, or peptide-loaded antigen-presenting cells as described in various experimental protocols . These approaches reveal how THEMIS functions within signaling complexes to regulate T-cell development and activation.

How does THEMIS contribute to pathogenic T-cell responses in autoimmunity models?

THEMIS plays significant roles in pathogenic T-cell responses, particularly in autoimmunity models:

Contribution to autoimmune processes:

• Enhances encephalitogenic responses to self-neuroantigens

• Promotes migration of pathogenic CD4+ T-cells into the central nervous system

• Required for optimal expression of T-BET and production of IFN-γ, key factors in type 1 autoimmune responses

Experimental evidence:

• Studies using post-thymic deletion of THEMIS demonstrate its role in promoting encephalitogenic responses in experimental autoimmune encephalomyelitis (EAE) models

• THEMIS deficiency results in reduced severity of autoimmune responses

Potential mechanisms:

• THEMIS-mediated enhancement of TH1 cell differentiation and function

• Promotion of inflammatory cytokine production

• Facilitation of pathogenic T-cell migration into target tissues

Understanding THEMIS's role in autoimmunity provides insights into potential therapeutic targets for autoimmune diseases. Researchers can use THEMIS antibodies to track expression levels in pathogenic versus non-pathogenic T-cells and correlate with disease progression in various autoimmunity models .

What role does THEMIS play in metabolic signaling in T-cells?

THEMIS appears to have important functions in T-cell metabolic signaling:

Observations from research:

• THEMIS-deficient CD4+ T-cells show poor proliferative responses and reduced cytokine production in vitro

• THEMIS regulates metabolic signaling and effector functions in CD4+ T-cells

• There may be links between THEMIS expression and insulin receptor (IR) regulation, as Themis-deficient CD4+ T-cells showed altered IR expression

Potential mechanisms:

• Regulation of key metabolic pathways required for T-cell activation and effector function

• Integration of TCR signaling with metabolic reprogramming during T-cell activation

• Influence on mTOR signaling pathways that coordinate metabolism and immune function

Research approaches:

• Metabolic flux analysis comparing THEMIS-sufficient and deficient T-cells

• Analysis of metabolic enzyme expression and activity

• Assessment of mitochondrial function and glycolytic capacity

The connection between THEMIS and cellular metabolism represents an emerging area of research that may explain some of the functional defects observed in THEMIS-deficient T-cells .

How can conditional THEMIS knockout models advance our understanding of THEMIS function?

Conditional THEMIS knockout models provide refined tools for investigating THEMIS function:

Advantages over conventional knockouts:

• Bypass embryonic or developmental defects

• Study THEMIS function at specific stages of T-cell development

• Restrict THEMIS deletion to specific T-cell subsets

• Avoid confounding effects from non-T-cell THEMIS expression

Key experimental approaches:

• Use Cre-loxP systems with tissue-specific or inducible promoters (CD4-Cre, Lck-Cre, CD4-CreERT2)

• Validate deletion using THEMIS antibodies by flow cytometry or Western blot

• Compare signaling responses between deleted and non-deleted populations

• Apply to disease models to assess THEMIS function in specific contexts

Research insights gained:

• Post-thymic deletion of THEMIS revealed its role in promoting TH1 cell function and pathogenic responses in autoimmunity models

• Stage-specific deletion helped distinguish THEMIS functions in thymic development versus peripheral T-cell responses

• Cell-type specific deletion identified differential requirements for THEMIS across T-cell subsets

When combined with THEMIS antibody-based detection methods, conditional knockout approaches allow precise dissection of THEMIS functions in different contexts and cell types .

What are the optimal storage conditions for THEMIS antibodies?

For optimal preservation of THEMIS antibodies, follow these storage guidelines:

Unopened/stock antibody:

• Store at -20°C to -70°C

• Use a manual defrost freezer to avoid temperature fluctuations

• Most THEMIS antibodies remain stable for 12 months from receipt date when stored properly

Reconstituted antibody:

• Short-term (≤1 month): Store at 2-8°C under sterile conditions

• Long-term (≤6 months): Aliquot and store at -20°C to -70°C under sterile conditions

Avoiding freeze-thaw cycles:

• Prepare small working aliquots upon first thaw

• Never refreeze thawed antibody aliquots

• Document date of reconstitution and number of freeze-thaw cycles

Following these storage recommendations will help maintain antibody activity and ensure consistent experimental results.

What quality control measures should be implemented when working with THEMIS antibodies?

Implementing rigorous quality control measures when working with THEMIS antibodies ensures reliable and reproducible results:

Initial validation:

• Test new antibody lots against a reference standard or previously validated lot

• Verify specificity using positive and negative controls (THEMIS-expressing and non-expressing samples)

• Perform titration experiments to determine optimal working concentration

Routine quality checks:

• Include standard positive controls in each experiment

• Monitor signal-to-background ratios over time

• Document lot numbers and correlate with experimental outcomes

• Store validation data and representative images/blots for reference

Application-specific controls:

• Western blot: Include molecular weight markers and loading controls

• Flow cytometry: Use isotype controls and FMO controls

• Immunoprecipitation: Include IgG control and input sample

Antibody handling:

• Keep antibodies on ice during experiments

• Return to appropriate storage conditions promptly after use

• Use clean pipette tips to avoid contamination

These quality control measures help identify potential issues early and ensure consistent performance of THEMIS antibodies across experiments .